FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200320281> ?p ?o ?g. }

• W4200320281 endingPage "1760" @default.
• W4200320281 startingPage "1755" @default.
• W4200320281 abstract "On October 29, 2021, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for Pfizer-BioNTech COVID-19 (BNT162b2) mRNA vaccine to expand its use to children aged 5-11 years, administered as 2 doses (10 μg, 0.2mL each) 3 weeks apart (1). As of December 19, 2021, only the Pfizer-BioNTech COVID-19 vaccine is authorized for administration to children aged 5-17 years (2,3). In preauthorization clinical trials, Pfizer-BioNTech COVID-19 vaccine was administered to 3,109 children aged 5-11 years; most adverse events were mild to moderate, and no serious adverse events related to vaccination were reported (4). To further characterize safety of the vaccine in children aged 5-11 years, CDC reviewed adverse events after receipt of Pfizer-BioNTech COVID-19 vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), a passive vaccine safety surveillance system co-managed by CDC and FDA, and adverse events and health impact assessments reported to v-safe, a voluntary smartphone-based safety surveillance system for adverse events after COVID-19 vaccination,* during November 3-December 19, 2021. Approximately 8.7 million doses of Pfizer-BioNTech COVID-19 vaccine were administered to children aged 5-11 years† during this period; VAERS received 4,249 reports of adverse events after vaccination with Pfizer-BioNTech COVID-19 vaccine in this age group, 4,149 (97.6%) of which were not serious. Approximately 42,504 children aged 5-11 years were enrolled in v-safe after vaccination with Pfizer-BioNTech COVID-19 vaccine; after dose 2, a total of 17,180 (57.5%) local and 12,223 systemic (40.9%) reactions (including injection-site pain, fatigue, or headache) were reported. The preliminary safety findings are similar to those from preauthorization clinical trials (4,5). The Advisory Committee on Immunization Practices (ACIP) recommends the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 years for the prevention of COVID-19 (6). Parents and guardians of children aged 5-11 years vaccinated with Pfizer-BioNTech COVID-19 vaccine should be advised that local and systemic reactions are expected after vaccination. Vaccination is the most effective way to prevent COVID-19. CDC and FDA will continue to monitor vaccine safety and will provide updates as needed to guide COVID-19 vaccination recommendations." @default.
• W4200320281 created "2021-12-31" @default.
• W4200320281 creator A5014457694 @default.
• W4200320281 creator A5017654848 @default.
• W4200320281 creator A5025817529 @default.
• W4200320281 creator A5031173584 @default.
• W4200320281 creator A5040342415 @default.
• W4200320281 creator A5048412798 @default.
• W4200320281 creator A5051327428 @default.
• W4200320281 creator A5059550323 @default.
• W4200320281 creator A5068468285 @default.
• W4200320281 creator A5073854301 @default.
• W4200320281 date "2021-12-31" @default.
• W4200320281 modified "2023-10-17" @default.
• W4200320281 title "COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021" @default.
• W4200320281 cites W3178327314 @default.
• W4200320281 cites W3189030052 @default.
• W4200320281 cites W3212487860 @default.
• W4200320281 cites W3214683919 @default.
• W4200320281 cites W4207051048 @default.
• W4200320281 cites W979396035 @default.
• W4200320281 doi "https://doi.org/10.15585/mmwr.mm705152a1" @default.
• W4200320281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34968370" @default.
• W4200320281 hasPublicationYear "2021" @default.
• W4200320281 type Work @default.
• W4200320281 citedByCount "119" @default.
• W4200320281 countsByYear W42003202812022 @default.
• W4200320281 countsByYear W42003202812023 @default.
• W4200320281 crossrefType "journal-article" @default.
• W4200320281 hasAuthorship W4200320281A5014457694 @default.
• W4200320281 hasAuthorship W4200320281A5017654848 @default.
• W4200320281 hasAuthorship W4200320281A5025817529 @default.
• W4200320281 hasAuthorship W4200320281A5031173584 @default.
• W4200320281 hasAuthorship W4200320281A5040342415 @default.
• W4200320281 hasAuthorship W4200320281A5048412798 @default.
• W4200320281 hasAuthorship W4200320281A5051327428 @default.
• W4200320281 hasAuthorship W4200320281A5059550323 @default.
• W4200320281 hasAuthorship W4200320281A5068468285 @default.
• W4200320281 hasAuthorship W4200320281A5073854301 @default.
• W4200320281 hasBestOaLocation W42003202811 @default.
• W4200320281 hasConcept C126322002 @default.
• W4200320281 hasConcept C159047783 @default.
• W4200320281 hasConcept C187212893 @default.
• W4200320281 hasConcept C197934379 @default.
• W4200320281 hasConcept C22070199 @default.
• W4200320281 hasConcept C2777105317 @default.
• W4200320281 hasConcept C71924100 @default.
• W4200320281 hasConceptScore W4200320281C126322002 @default.
• W4200320281 hasConceptScore W4200320281C159047783 @default.
• W4200320281 hasConceptScore W4200320281C187212893 @default.
• W4200320281 hasConceptScore W4200320281C197934379 @default.
• W4200320281 hasConceptScore W4200320281C22070199 @default.
• W4200320281 hasConceptScore W4200320281C2777105317 @default.
• W4200320281 hasConceptScore W4200320281C71924100 @default.
• W4200320281 hasIssue "5152" @default.
• W4200320281 hasLocation W42003202811 @default.
• W4200320281 hasLocation W42003202812 @default.
• W4200320281 hasLocation W42003202813 @default.
• W4200320281 hasOpenAccess W4200320281 @default.
• W4200320281 hasPrimaryLocation W42003202811 @default.
• W4200320281 hasRelatedWork W1965095189 @default.
• W4200320281 hasRelatedWork W2061769992 @default.
• W4200320281 hasRelatedWork W2064875681 @default.
• W4200320281 hasRelatedWork W2068173199 @default.
• W4200320281 hasRelatedWork W2468473435 @default.
• W4200320281 hasRelatedWork W3180796651 @default.
• W4200320281 hasRelatedWork W3193415847 @default.
• W4200320281 hasRelatedWork W4200045268 @default.
• W4200320281 hasRelatedWork W4214806105 @default.
• W4200320281 hasRelatedWork W4280635892 @default.
• W4200320281 hasVolume "70" @default.
• W4200320281 isParatext "false" @default.
• W4200320281 isRetracted "false" @default.
• W4200320281 workType "article" @default.